Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 May 12;334(7601):982.
doi: 10.1136/bmj.39202.399942.AD.

Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes

Scott M Grundy  1
Affiliations

Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes

Scott M Grundy. BMJ. .

Abstract

Women in western countries are more likely to die from heart disease than from cancer. Scott M Grundy argues that the risks make preventive treatment essential, but Malcolm Kendrick believes the evidence of benefit is not strong enough

PubMed Disclaimer

Conflict of interest statement

Competing interests: SMG has been a consultant to the following companies that market statins: Merck, Pfizer, Bristol Myers Squibb, and Astra Zeneca.

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Final report. Circulation 2002;106:3143-421. - PubMed
    1. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program adult treatment panel III guidelines. Circulation 2004;110:227-39. - PubMed
    1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-9. - PubMed
    1. Sacks FM, Tonkin AM, Shepherd J, Braunwald E, Cobbe S, Hawkins CM, et al. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the prospective pravastatin pooling project. Circulation 2000;102:1893-900. - PubMed
    1. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22. - PubMed

Substances